Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: The undiscovered country
Article first published online: 27 MAY 2005
DOI: 10.1111/j.1041-2972.2005.00034.x
Issue

Journal of the American Academy of Nurse Practitioners
Volume 17, Issue 6, pages 207–212, June 2005
Additional Information
How to Cite
Crigger, N. J. (2005), Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: The undiscovered country. Journal of the American Academy of Nurse Practitioners, 17: 207–212. doi: 10.1111/j.1041-2972.2005.00034.x
Publication History
- Issue published online: 27 MAY 2005
- Article first published online: 27 MAY 2005
- Abstract
- Article
- References
- Cited By
Keywords:
- Conflict of interest;
- ethics;
- decision making;
- pharmaceutical industry;
- gift giving;
- fiduciary role;
- advocate
Purpose
To increase nurse practitioners’ (NPs) awareness of the conflict of interest that exists between the NPs’ primary goal of making the best medication choices for patients and the potentially negative impact that the pharmaceutical industry's marketing strategies have on these choices.
Data sources
Selected healthcare professional, philosophical, and bioethical literature was reviewed.
Conclusions
Healthcare professionals are given gifts, dinners, and other inducements in the drug industry's effort to increase consumerism and drug sales. The current method of drug promotion increases sales but also increases healthcare expenses. Research also indicates that the pharmaceutical marketing strategies influence the judgments that NPs and other healthcare professionals make about patient care and drug prescriptions.
Implications
Guidelines are presented that can reduce the likelihood that any conflict of interest that exists will influence NPs’ decisions about patient care.

1745-7599/asset/JAAN_centre.gif?v=1&s=0091885d2a51bdd0abf3dcd12524a9f0337f1ff4)